The intricate world of drug discovery hinges on the availability of precise and potent chemical building blocks. 2,4-Difluoro-5-Nitrobenzonitrile, bearing the CAS number 67152-20-9, has emerged as a highly significant intermediate, particularly in the realm of oncology drug development. Its primary role as a precursor for synthesizing tankyrase inhibitors, compounds vital for halting tumorigenesis, positions it at the forefront of cancer research. NINGBO INNO PHARMCHEM CO.,LTD., a distinguished pharmaceutical intermediate manufacturer, ensures the supply of this critical component.

The molecular architecture of 2,4-Difluoro-5-Nitrobenzonitrile, featuring strategically placed fluorine atoms and a nitro group on a benzonitrile framework, grants it unique reactivity and selectivity. These attributes are indispensable for creating pharmaceuticals that can precisely target disease mechanisms. For scientists engaged in drug discovery, sourcing reliable CAS 67152-20-9 is paramount. As a leading 2,4-Difluoro-5-Nitrobenzonitrile supplier, NINGBO INNO PHARMCHEM CO.,LTD. provides materials that meet stringent purity requirements, often exceeding 98.0%, which is critical for successful drug synthesis and validation.

The development of effective therapies often relies on access to specialized tankyrase inhibitor synthesis intermediates. Our role as a key player in the supply of these advanced chemical building blocks, including various fluorinated benzonitrile derivatives, empowers research institutions and pharmaceutical companies. We are committed to supporting innovation by ensuring a consistent and high-quality supply of 2,4-Difluoro-5-Nitrobenzonitrile. This dedication cements our position as a vital contributor to the ongoing advancements in drug discovery, providing the essential components needed to bring life-saving treatments from the lab to the patients.